M.H. MediCane

MediCane Health is an international pharmaceutical company specializing in the research, development, and commercialization of cannabis-based therapies. The company operates a vertically integrated model with R&D facilities in Israel and a large-scale EU-GMP manufacturing site in Portugal. MediCane's clinical pipeline focuses on addressing unmet medical needs in neurology and gastroenterology, with lead programs targeting behavioral symptoms of dementia and inflammatory conditions. By combining pharmaceutical standards with proprietary genetics, the company aims to deliver standardized, evidence-based cannabinoid medicines to global markets.